Status:

UNKNOWN

Urinary Cytokine Levels as a Prognostic Marker for Kidney Scarring After Pyelonephritis

Lead Sponsor:

Hillel Yaffe Medical Center

Conditions:

Kidney Scarring Post-Febrile UTI

Eligibility:

All Genders

Up to 7 years

Brief Summary

The prevalence of kidney scarring after UTI is approximately 5-57%. UTIs are caused mainly by bacteria that cause local and systemic immunological reaction that are accompanied by cytokines. These cyt...

Eligibility Criteria

Inclusion

  • Children aged 0-7
  • First episode febrile UTI

Exclusion

  • Recurrent UTI

Key Trial Info

Start Date :

May 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

35 Patients enrolled

Trial Details

Trial ID

NCT00868270

Start Date

May 1 2009

Last Update

March 24 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hillel Yaffe Medical Center

Hadera, Israel, 38100

Urinary Cytokine Levels as a Prognostic Marker for Kidney Scarring After Pyelonephritis | DecenTrialz